Advertisement
News
Subscribe to MDT Magazine News

VeriStrat® Test Identifies Lung Cancer Patients Benefiting from Combination Therapy

November 19, 2010 4:35 am | by Bio-Medicine.Org | Comments

BROOMFIELD, Colo., Nov. 19, 2010 /- Results from the VeriStrat analysis of a phase II trial of first line erlotinib in combination with sorafenib in patients with advanced non-small cell lung cancer (NSCLC) were presented today at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets in...

TOPICS:

Masimo to Present at Piper Jaffray 22nd Annual Healthcare Conference

November 19, 2010 4:34 am | by Bio-Medicine.Org | Comments

IRVINE, Calif., Nov. 19, 2010 /- Masimo (Nasdaq: MASI ) today announced that its management is scheduled to present at the Piper Jaffray 22nd Annual Healthcare Conference at The New York Palace in New York City on Tuesday, November 30, at 12:30 p.m. ET.  A live audiocast of the...

TOPICS:

Siemens Unveils Biograph mMR Whole-Body Integrated MR-PET System Capable of Simultaneous Data Acquisition

November 19, 2010 4:34 am | by Bio-Medicine.Org | Comments

MALVERN, Pa., Nov. 19, 2010 /- At the 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), November 28 - December 2 in Chicago, Siemens Healthcare (Booth #822, East Building/Lakeside Center, Hall D) will unveil the Biograph™ mMR*, the...

TOPICS:
Advertisement

Spain is leading the fight against rare anemias in Europe

November 19, 2010 2:33 am | by EurekAlert | Comments

(IDIBAPS - Institut d'Investigacions Biomèdiques August Pi i Sunyer) Health care professionals and patients get together for the first time in Spain against rare anemias. One percent of couples are at risk of having a newborn who suffers a severe hemoglobin syndrome. In Spain the...

TOPICS:

Boston Scientific Announces CE Mark Approval and First Implants for New Devices to Treat Heart Failure and Sudden Cardiac Death

November 19, 2010 1:34 am | by Boston Scientific | Comments

NATICK, Mass., Nov. 19, 2010 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval of its INCEPTA™, ENERGEN™ and PUNCTUA™ cardiac resynchronization therapy defibrillators (CRT-Ds) and impl

TOPICS:

Inspiration Biopharmaceuticals Treats First Patient in Pivotal Study of OBI-1 for Acquired Hemophilia A

November 18, 2010 10:35 pm | by Bio-Medicine.Org | Comments

LAGUNA NIGUEL, Calif., Nov. 19, 2010 /- Inspiration Biopharmaceuticals, Inc. (Inspiration) today announced the Company has initiated treatment of patients in a pivotal clinical study of OBI-1, an intravenous recombinant porcine factor VIII (FVIII) product, for the treatment of acquired...

TOPICS:

Businessman-philanthropist assists TGen-VARI study of rare cancer

November 18, 2010 10:33 pm | by EurekAlert | Comments

(The Translational Genomics Research Institute) International businessman and philanthropist Foster Friess has donated $50,000 to help launch a study of small cell carcinoma of the ovary by the Translational Genomics Research Institute and the Van Andel Research Institute.

TOPICS:

Light flow controlled with all-optical transistor

November 18, 2010 8:37 pm | by I-Micronews | Comments

By discovering how to couple light and vibrations, scientists have built a device in which a beam of light traveling through an optical microresonator could be controlled by a second, stronger light beam. The device acts like an optical transistor, in which one light beam influences the...

Advertisement

Fraunhofer solves power grid converter station problem

November 18, 2010 8:37 pm | by I-Micronews | Comments

Scientists and researchers at the Fraunhofer Institute for Integrated Systems and Device Technology (IISB) in Erlangen, Germany, said they have solved a major challenge that stumped them while building converter stations for power grids of the ...

Reports claiming ALS caused by head trauma lacks scientific validation

November 18, 2010 8:33 pm | by EurekAlert | Comments

(Wiley-Blackwell) A recent study suggesting that amyotrophic lateral sclerosis (ALS) may be attributed to "repetitive head trauma experienced in collision sports" lacks scientific epidemiological evidence to support this claim. In a review of the 12-patient study, several experts...

TOPICS:

Sensors for defense and security: launch of European business roundtable

November 18, 2010 7:35 pm | by I-Micronews | Comments

A group of European defense integrators and photonics clusters has today launched a Business Round Table for Photonics Sensors for Defense and Security (www.photonics-sensors.eu).

How Brain Imaging Could Help Predict Alzheimer's

November 18, 2010 7:34 pm | by Massachusetts Institute of Technology | Comments

The discovery could one day allow doctors to catch the disease before it's done irreversible damage.

TOPICS:

MIT scientist wins $1.3M grant from Paul Allen foundation

November 18, 2010 2:37 pm | by Mass High Tech: The Journal of New England Technology | Comments

An MIT professor and researcher has landed a million dollar-plus share of $9.4 million given out by the Paul G. Allen Family Foundation to advance neuroscience and cellular engineering research.

TOPICS:

Express Scripts ramps up lobbying to $430K in 3Q

November 18, 2010 11:45 am | by The Associated Press | Comments

Pharmacy benefit manager Express Scripts Inc. spent $430,000 in the third quarter lobbying the federal government on issues including prescription drug prices and federal health care programs.Express Scripts said its lobbying interests included the drug prices and reimbursement rates,...

Concord Medical 3Q profit falls on costs

November 18, 2010 11:45 am | by The Associated Press | Comments

Concord Medical Services Holdings Ltd., a radiation therapy and diagnostic imaging center operator in China, said Thursday that its third-quarter net income fell 2 percent on rising costs.Concord said its net income fell to 33.4 million yuan ($5 million) from 22.3 million yuan, during the same...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading